Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × ipatasertib × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 9 INDUSTRY 9 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 42 Docetaxel 33 Paclitaxel 31 Tamoxifen 29 Doxorubicin 29 Trastuzumab 24 Radiotherapy 20 Epirubicin 16 Letrozole 15 Anastrozole 12 exemestane 11 Fluorouracil 11 Capecitabine 10 Bevacizumab 10 palbociclib 9 Immunohistochemistry 9 Fulvestrant 9 Filgrastim 9 Lapatinib 8 Methotrexate 7 Gene Expression Profiling 7 Zoledronic Acid 6 Triptorelin Pamoate 6 Taxes 6 Surgical Procedures, Operative 6 Microarray Analysis 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Carboplatin 6 Amplified Fragment Length Polymorphism Analysis 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04650581 2026-04-13

FINER

Canadian Cancer Trials Group

Phase 3 Active not recruiting

250 enrolled 13 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡